Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DWP14012 for erosive esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED